Literature DB >> 28417657

A "kissing lesion": In-vivo 7T evidence of meningeal inflammation in early multiple sclerosis.

Pierre Kolber1, Amgad Droby1, Alard Roebroeck2, Rainer Goebel2, Vinzenz Fleischer1, Sergiu Groppa1, Frauke Zipp1.   

Abstract

BACKGROUND: The role of cortical lesions (CLs) in disease progression and clinical deficits is increasingly recognized in multiple sclerosis (MS); however the origin of CLs in MS still remains unclear.
OBJECTIVE: Here, we report a para-sulcal CL detected two years after diagnosis in a relapsing-remitting MS (RRMS) patient without manifestation of clinical deficit.
METHODS: Ultra-high field (7T) MR imaging using magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE) sequence was performed.
RESULTS: A para-sulcal CL was detected which showed hypointense rim and iso- to hyperintense core. This was detected in the proximity of the leptomeninges in the left precentral gyrus extending to the adjacent postcentral gyrus.
CONCLUSION: This finding indicates that inflammatory infiltration into the cortex through the meninges underlies cortical pathology already in the early stage of disease and in mild disease course.

Entities:  

Keywords:  7T; Multiple sclerosis; atypical cortical lesions; magnetic resonance imaging

Mesh:

Year:  2017        PMID: 28417657     DOI: 10.1177/1352458516683267

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  2 in total

1.  In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?

Authors:  Iris D Kilsdonk; Menno Schoonheim; Mike P Wattjes
Journal:  Mult Scler       Date:  2017-04-18       Impact factor: 6.312

2.  Gray matter network reorganization in multiple sclerosis from 7-Tesla and 3-Tesla MRI data.

Authors:  Gabriel Gonzalez-Escamilla; Dumitru Ciolac; Silvia De Santis; Angela Radetz; Vinzenz Fleischer; Amgad Droby; Alard Roebroeck; Sven G Meuth; Muthuraman Muthuraman; Sergiu Groppa
Journal:  Ann Clin Transl Neurol       Date:  2020-04-07       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.